Inari Medical, Inc. / Fundamentals

    Income statement

    Net revenue
    €492.92M
    Cost of goods sold
    €69.00M
    Gross profit
    €423.92M
    SG&A expenses
    €357.82M
    R&D expenses
    €89.32M
    EBITDA
    -€31.02M
    D&A
    €14.50M
    EBIT
    -€41.20M
    Interest expenses
    €259.12K
    EBT
    -€45.78M
    Tax expenses
    €21.64M
    Net income
    -€67.43M

    Cash flow statement

    Net deferred tax
    -€501.07K
    Non-cash items
    €38.59M
    Changes in working capital
    €8.57M
    Operating cash flow
    €12.16M
    Capex
    €10.81M
    Other investing cash flow
    €156.48M
    Net investing cash flow
    -€51.97M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €858.00
    Debt repayment
    €0.00
    Other financing cash flow
    -€4.93M
    Net financing cash flow
    -€1.51M
    Foreign exchange effects
    €152.72K
    Net change in cash
    -€41.16M
    Cash at end of period
    €35.36M
    Free cash flow
    €22.97M

    Balance sheet

    Cash and cash equivalents
    €35.30M
    Cash and short-term investments
    €95.70M
    Total receivables
    €72.42M
    Inventory
    €47.37M
    Other current assets
    €10.50M
    Total current assets
    €225.99M
    Property, plant & equipment
    €62.12M
    Goodwill
    €183.05M
    Intangible assets
    €123.39M
    Long-term investments
    €0.00
    Other non-current assets
    €3.69M
    Total non-current assets
    €372.25M
    Total assets
    €598.23M
    Accounts payable
    €13.32M
    Short-term debt
    €2.71M
    Other current liabilities
    €111.63M
    Total current liabilities
    €127.65M
    Long-term debt
    €26.72M
    Deferred tax liabilities
    €31.53M
    Other non-current liabilities
    €39.30M
    Total non-current liabilities
    €97.55M
    Total liabilities
    €225.21M
    Common stock
    €49.76K
    Retained earnings
    -€105.02M
    Other equity
    €11.28M
    Total equity
    €373.03M
    Total liabilities and shareholders' equity
    €598.23M

    Company information

    Market capitalization
    €3.99B
    Employees
    1.3K
    Enterprise Value
    €4.67B

    Company ratios

    Gross margin
    86.0% Much better than peer group: 40.2%
    EBITDA margin
    -6.3% Much better than peer group: -163,337.8%
    EBIT margin
    -8.4% Much better than peer group: -170,322.6%
    EBT margin
    -9.3% Much better than peer group: -170,553.2%
    Net margin
    -13.7% Much better than peer group: -170,548.1%
    ROE
    -18.1% Better than peer group: -24.8%
    ROA
    -11.3% Better than peer group: -17.2%
    Asset turnover
    82.4% Much better than peer group: 56.6%
    FCF margin
    0.3% Much better than peer group: -184,834.6%
    FCF yield
    0.0%
    Efficiency ratio
    106.3%
    Net sales per employee
    €379.17K
    Net income per employee
    -€51.87K

    Notifications